Research carried out in Ireland on a new high-tech test to detect early stage breast cancer shows it reduced the need for chemotherapy in almost 3 out of 5 patients.
583 patients underwent the Oncotype Dx DNA test, and of those 339 avoided chemotherapy.
The test predicts the likelihood of chemotherapy benefit as well as the risk of recurrence in early-stage breast cancer.
Advertisement
Ireland is the first European country to publicly fund the test, which was carried out over an 18 month period in eight Irish hospitals.
Consultant Medical Oncologist and Clinical Lead on the study Dr Janice Walsh says the findings will allow for more tailored treatment options:
